Abstract
ObjectiveThis study sought to elucidate the molecular impacts of belimumab (BEL) treatment on T-cell immune profiling in SLE.MethodsWe used mass cytometry with 25 marker panels for T-cell immune profiling in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
